Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

OBJECTIVE: Endocrine therapy is frequently administered in patients with hormone dependent (HR+) metastatic endometrial cancer. ESR1 mutations have emerged as a key mechanism of aromatase inhibitor (AI) resistance in HR + metastatic breast cancer and can be monitored using circulating tumor DNA (ctD...

Descripción completa

Detalles Bibliográficos
Autores principales: Drouyer, Aurélien, Beaussire, Ludivine, Jorda, Pauline, Leheurteur, Marianne, Guillemet, Cécile, Berghian, Anca, Georgescu, Dragos, Di Fiore, Frédéric, Perdrix, Anne, Clatot, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625264/
https://www.ncbi.nlm.nih.gov/pubmed/37924026
http://dx.doi.org/10.1186/s12885-023-11559-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625264/
https://www.ncbi.nlm.nih.gov/pubmed/37924026
http://dx.doi.org/10.1186/s12885-023-11559-x

Ejemplares similares